CJC-1295 (No DAC) + Ipamorelin is a research blend that combines CJC-1295 (No DAC) and Ipamorelin. In a research context, this combination is studied for growth-hormone signaling, peptide-receptor interactions, and endocrine regulatory pathways.
Each one is also studied on its own, and the blend lets researchers explore complementary pathways like pulsatile hormone release and receptor activation in one formulation (Teichman et al., 2006). That overlap is a common reason combination peptides are used in research.
Research Applications
- Growth-hormone signaling research
- Peptide-receptor interaction studies
- Endocrine regulatory pathway research
- Multi-pathway combination research
Supplied as a lyophilized powder for stability.
See also: CJC-1295 No DAC 10 mg, Ipamorelin 10 mg, and CJC-1295 (No DAC) + Ipamorelin (10 mg) (Blend).
Reviews
There are no reviews yet.